colforsin has been researched along with opipramol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpéné, C; García-Barrado, MJ; Hernandez-Gonzalez, D; Iglesias-Osma, MC; Perrier, K; Viana, P | 1 |
1 other study(ies) available for colforsin and opipramol
| Article | Year |
|---|---|
The anxiolytic drug opipramol inhibits insulin-induced lipogenesis in fat cells and insulin secretion in pancreatic islets.
Topics: Adipocytes; Animals; Anti-Anxiety Agents; Colforsin; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Lipids; Lipogenesis; Lipolysis; Mice; Opipramol; Rats | 2023 |